Trevi Therapeutics (TRVI) Q3 2023 Earnings

9NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.1
-0.09
-0.07
-0.06

Details

Expected EPS
-0.09
Actual EPS
-0.08
Surprise EPS
0.01
Surprise Percent
+11.11%

Description

Trevi Therapeutics (TRVI) has reported earnings of -0.08 per share for Q3 2023.

0 Comments

Share your thoughts